CBT-I as Early Intervention of Mood Disorders

Not Applicable

Completed

• Conditions: Insomnia Due to Mental Disorder
• Interventions: Behavioral: Cognitive Behavioral Therapy for Insomnia (CBT-I)

• Registration Number: NCT03000894
• Lead Sponsor: The University of Hong Kong

Brief Summary

This study aims to investigate the effectiveness of transdiagnostic nurse-administered 4-session group cognitive behavioral therapy for insomnia (CBT-I) plus standard care, compared to standard care alone, for improving sleep and daytime function, enhancing recovery, preventing relapses, and reducing medication burden in patients with the first episode of mood disorders.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2016-12-12
• Study First Submitted QC: 2016-12-19
• Study First Posted: 2016-12-22
• Study Start: 2017-01
• Primary Completion: 2020-01
• Study Completion: 2020-01
• Status Verified: 2020-03
• Last Update Submitted: 2020-03-23
• Last Update Posted: 2020-03-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Hong Kong residents
• Aged ≥ 18 years
• Able to to communicate in Cantonese and write in Chinese
• First episode of depressive or bipolar disorders according to the DSM-5 diagnostic criteria
• Having received psychiatric treatment for less than 12 months
• Meeting the DSM-5 diagnostic criteria for insomnia disorder for at least 1 month, instead of at least 3 months, as in criterion D.

Read More

Exclusion Criteria

• Significant cognitive impairments and psychotic symptoms, based on a Mini-mental State Examination score of 23 or below and the Positive and Negative Syndrome Scale items on delusions, conceptual disorganization, and hallucinatory behavior at moderate severity or above
• A diagnosis of schizophrenia, delusional disorder, neurocognitive disorders, or learning disability
• Having a highly unstable medical or psychiatric condition (including strong suicidal risk) that requires hospitalization
• Having an untreated sleep disorder, including narcolepsy, obstructive sleep apnea, and periodic leg movement disorder
• Past or current treatment with CBT-I
• Having a fear of speaking in a group setting or refusal to give informed consent
• Refuse to give informed consent

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
CBT-I plus standard care	Cognitive Behavioral Therapy for Insomnia (CBT-I)	The group CBT-I will receive both CBT-I and standard care. CBT-I covers sleep-wake cycle as well as sleep hygiene education, activity scheduling, stimulus control, sleep restriction, relaxation training, and cognitive therapy. Standard care will include those treatments provided by the psychiatrists according to their clinical needs.

Primary Outcome Measures

Name	Time	Method
Chang of subjects'' self-rated score of severity of insomnia symptoms and functional impairment measured by Insomnia Severity Index (ISI) questionnaire	Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline

Secondary Outcome Measures

Name	Time	Method
Change of the severity of depression symptoms measured by 17-item Hamilton Depression Rating Scale (HAM-D17)	Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
The number of clinic visits and hospitalizations	3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
Change of subjects' perceived stress measured by Perceived Stress Scale	Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
Change of the severity of illness measured by Clinical Global Impressions of Severity (CGI-S)	Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
The number and type of relapses	3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
Change of subjects' cognitive and somatic arousal prior to sleep onset measured by Pre-sleep Arousal Scale	Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
Change of the anxiety and depression state measured by Hospital Anxiety and Depression Scale(HADS)	Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
Change of subjects' self-rated severity of physical symptoms measured by Somatic Symptom Inventory (SSI)	Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
Change of subjects' sleep inhibitory behavior measured by the Sleep Hygiene Practice Scale	Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
Change of subjects' likeliness of dozing measured by Epworth Sleepiness Scale (ESS)	Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
Change of subjects' self-rated fatigue score measured by Multidimensional Fatigue Inventory (MFI)	Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
Change of subjects' self-rated score of health state measured by 36-item Short Form Health Survey (SF-36)	Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
Change of subjects' credibility to treatment measured by Credibility of treatment rating scale	Baseline and immediate post-treatment, around 8-week post-baseline (CBT-I group), Baseline (Control group)
Change of the severity of mania symptoms measured by Young Mania Rating Scale(YMRS)	Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
Change of subjects' functioning regarding work/study, social life and family measured by Sheehan Disability Scale (SDS)	Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
Change of subjects' self-efficacy about sleep measured by Self-Efficacy for Sleep Scale	Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
Prescribed medication burden	3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
Subjects' satisfaction to CBT-I measured by treatment satisfaction scale	Immediate post-treatment (around 8-week post-baseline)
Subjects' adherence to CBT-I measured by treatment adherence scale	Immediate post-treatment (around 8-week post-baseline)
Change of subjects' sleep-incompatible beliefs and cognition measured by 16-item Dysfunctional Beliefs and Attitudes About Sleep Scale	Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline

Trial Locations

Locations (1)

Queen Mary Hospital; 🇭🇰 Hong Kong, Hong Kong